Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Deterioration of Parkinson's disease during hospitalization: survey of 684 patients.

Gerlach OH, Broen MP, van Domburg PH, Vermeij AJ, Weber WE.

BMC Neurol. 2012 Mar 8;12:13. doi: 10.1186/1471-2377-12-13.

2.

Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study.

Gerlach OH, Broen MP, Weber WE.

Parkinsonism Relat Disord. 2013 Aug;19(8):737-41. doi: 10.1016/j.parkreldis.2013.04.017. Epub 2013 May 13.

PMID:
23680419
3.

Medication management in people with Parkinson's disease during surgical admissions.

Derry CP, Shah KJ, Caie L, Counsell CE.

Postgrad Med J. 2010 Jun;86(1016):334-7. doi: 10.1136/pgmj.2009.080432.

PMID:
20547599
4.

The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.

Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL; PKDS009 Study Group.

CNS Drugs. 2004;18(11):733-46. Erratum in: CNS Drugs. 2005;19(7):633.

PMID:
15330687
5.

Ropinirole: a review of its use in the management of Parkinson's disease.

Matheson AJ, Spencer CM.

Drugs. 2000 Jul;60(1):115-37. Review.

PMID:
10929932
6.

Motor fluctuations in Parkinson's disease.

Denny AP, Behari M.

J Neurol Sci. 1999 May 1;165(1):18-23.

PMID:
10426141
7.

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.

N Engl J Med. 2003 Nov 13;349(20):1925-34.

8.

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.

N Engl J Med. 1998 Oct 15;339(16):1105-11.

9.

Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.

Martinez-Ramirez D, Giugni JC, Little CS, Chapman JP, Ahmed B, Monari E, Wagle Shukla A, Hess CW, Okun MS.

PLoS One. 2015 Apr 17;10(4):e0124356. doi: 10.1371/journal.pone.0124356. eCollection 2015.

10.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group.

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
11.

Comparison of the Unified Parkinson's Disease Rating Scale and the Short Parkinson's Evaluation Scale in patients with Parkinson's disease after levodopa loading.

Rabey JM, Klein C, Molochnikov A, Van Hilten B, Krauss P, Bonuccelli U.

Clin Neuropharmacol. 2002 Mar-Apr;25(2):83-8.

PMID:
11981234
12.

Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.

Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.

Int J Clin Pract. 2009 Apr;63(4):613-23. doi: 10.1111/j.1742-1241.2009.02027.x. Epub 2009 Feb 16.

PMID:
19222614
13.

[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].

Bailbé M, Karolewicz S, Neau JP, Dumas P, Gil R; Association des neurologues du Poitou-Charentes.

Rev Neurol (Paris). 2002 Feb;158(2):203-10. French.

PMID:
11965176
14.

Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.

Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD.

Drugs. 1998;55 Suppl 1:23-30.

PMID:
9483167
15.

Original research: The perioperative experience of patients with Parkinson's disease: a qualitative study.

Anderson LC, Fagerlund K.

Am J Nurs. 2013 Feb;113(2):26-32; quiz 33. doi: 10.1097/01.NAJ.0000426686.84655.4a.

PMID:
23334560
16.

Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.

Müller T, Voss B, Hellwig K, Josef Stein F, Schulte T, Przuntek H.

CNS Drugs. 2004;18(2):105-11.

PMID:
14728057
17.

Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.

Fagerlund K, Anderson LC, Gurvich O.

Am J Nurs. 2013 Jan;113(1):26-35; quiz 36. doi: 10.1097/01.NAJ.0000425744.76107.9f.

PMID:
23247677
18.

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.

Hely MA, Morris JG, Reid WG, Trafficante R.

Mov Disord. 2005 Feb;20(2):190-9.

PMID:
15551331
19.

Decreased dopaminergic treatment of hospitalized Parkinson's disease patients during infectious diseases is associated with poor outcomes.

Segal O, Hassin-Baer S, Rosman M, Segal G.

J Clin Neurosci. 2015 Aug;22(8):1272-4. doi: 10.1016/j.jocn.2015.02.010. Epub 2015 Apr 22.

PMID:
25911502
20.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section.

N Engl J Med. 2006 Aug 31;355(9):896-908. Erratum in: N Engl J Med. 2006 Sep 21;355(12):1289.

Supplemental Content

Support Center